IndiaTickerBharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBI'S LODR.
BSE · exchange filing · pdf
Source filing Company dossier
Bharat Immunologicals
BSE:BIBCL · ISIN INE994B01014
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Bharat Immunologicals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBI'S LODR.BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Compliance Of Regulation 34 Of LODR 2015 And Submission Annual Report For 34Th Annual General Meeting Scheduled On 29.12.2023.BSE · annual report · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Compliance Of The Regulation Of LODR 2015 For The Intimation Of Book Closure Period (22.12.2023 To 29.12.2023) Of The Company In Respect Of 34Th Annual General Meeting Scheduled To Be Held On 29.12.2023.BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Submission Of Notice Of 34Th Annual General Meeting On 29.12.2023 As Compliance Of The Provision Of LODR 2015.BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Submission Of Unaudited Quarterly Financial Results Alongwith Limited Review Report For The Quarter Ended June 2023 As Compliance Of LODR 2015BSE · financial results · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Submission Of Unaudited Quarterly Financial Results Alongwith Limited Review Report For The Quarter And Half Year Ended September 2023 As Compliance Of LODR 2015BSE · financial results · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 31St October 2023 Under Regulation 29 Of SEBI'S LODR.BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Submission Of Signed Audited Annual Accounts 2022-23 Alongwith Statutory Audit Report Thereof Provided By The Statutory Auditor Appointed By Comptroller & Auditor General Of India (C&AG).BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Submission Of Annual Accounts For The Financial Year Ended On 31.03.2023 And Is Under Audit Of Statutory Auditor Appointed By C&AGBSE · financial results · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Compliance Certificate Under Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ending On 31.03.2023.BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Certificate From Practicing Company Secretary Under Regulation 40 (9) Of SEBI (LODR) Regulations 2015 For The Year Ended 31.03.2023BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 17Th April 2023 Under Regulation 29 Of SEBI'S LODR.BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Update on board meetingBSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Submission Of Unaudited Quarterly Financial Results For The Quarter And Nine Months Ended December 2022 Along With Limited Review ReportBSE · financial results · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 09Th February 2023 Under Regulation 29 Of SEBI'S LODR.BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Outcome for Submission Of Un-Audited Quarterly Financial Results For The Quarter Ended September 2022 And Limited Review Report Thereon As Per The Compliance Of LODR 2015BSE · financial results · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 17Th October 2022BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI LODR 2015 For The Year 2021-22.BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Compliance Of The Regulation Of LODR 2015 For The Intimation Of Book Closure Period (23.09.2022 To 30.09.2022) Of The Company In Respect Of 33Rd Annual General Meeting Scheduled To Be Held On 30.09.2022.BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Submission Of Notice Of 33Rd Annual General Meeting On 30.09.2022 As Compliance Of The Provision Of LODR 2015.BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Outcome for Submission Of Un-Audited Quarterly Financial Results For The Quarter Ended June 2022 And Limited Review Report Thereon As Per The Compliance Of LODR 2015BSE · financial results · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 11Th August 2022 Under Regulation 29 Of SEBI'S LODR.BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Certificate From Practicing Company Secretary Under Regulation 40 (9) Of SEBI (LODR) Regulations 2015 For The Year Ended 31.03.2022BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Submission Of Reviewed Annual Financial Results For The Year Ended 31.03.2022BSE · financial results · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 30Th May 2022 Under Regulation 29 Of SEBI'S LODR.BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Outcome for Submission Of Unaudited Quarterly Financial Results For The Quarter Ended December 2021 As Compliance Of LODR 2015BSE · financial results · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Submission Of Limited Review Report Of The Quarterly Unaudited Financial Results For The Quarter Ended December 2021 Under Regulation 33(3)(C ) Of LODRBSE · financial results · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 8Th February 2022 Under Regulation 29 Of SEBI'S LODRBSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Submission Of Limited Review Report Of The Quarterly Unaudited Financial Results For The Quarter Ended September 2021 Under Regulation 33(3)(C ) Of LODR, Related Party Transaction - NILBSE · financial results · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Submission Of Limited Review Report Of The Quarterly Unaudited Financial Results For The Quarter Ended September 2021 Under Regulation 33(3)(C ) Of LODRBSE · financial results · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Reg. 34 (1) Annual ReportBSE · annual report · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Submission Of Notice Of 32Nd Annual General Meeting On 30.11.2021 As Compliance Of The Provision Of LODR 2015BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Compliance Of The Regulation Of LODR 2015 For The Intimation Of Book Closure Period (23.11.2021 To 30.11.2021) Of The Company In Respect Of 32Nd Annual General Meeting Scheduled To Be Held On 30.11.2021.BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Outcome for Submission Of Unaudited Quarterly Financial Results For The Quarter And Half Year Ended September 2021 As Compliance Of LODR 2015BSE · financial results · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 29Th October 2021 Under Regulation 29 Of SEBI'S LODR.BSE · exchange filing · pdf
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Submission Of Limited Review Report On Unaudited Quarterly Financial Results For Quarter Ended June 2021In Compliance Of SEBI LODR Please.BSE · financial results · pdf
Source filing